H S Boswell
Overview
Explore the profile of H S Boswell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
777
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen S, Gao R, Yao C, Kobayashi M, Liu S, Yoder M, et al.
Leukemia
. 2017 Dec;
32(3):850-854.
PMID: 29263439
No abstract available.
2.
OLeary H, Capitano M, Cooper S, Mantel C, Boswell H, Kapur R, et al.
Leukemia
. 2017 Mar;
31(11):2468-2478.
PMID: 28344320
Dipeptidylpeptidase 4 (DPP4/CD26) enzymatically cleaves select penultimate amino acids of proteins, including colony-stimulating factors (CSFs), and has been implicated in cellular regulation. To better understand the role of DPP4 regulation...
3.
Kobayashi M, Chen S, Bai Y, Yao C, Gao R, Sun X, et al.
Leukemia
. 2017 Feb;
31(6):1453-1457.
PMID: 28220038
No abstract available.
4.
Richine B, Virts E, Bowling J, Ramdas B, Mali R, Naoye R, et al.
Leukemia
. 2016 Jun;
30(10):2094-2097.
PMID: 27256702
No abstract available.
5.
Nabinger S, Li X, Ramdas B, He Y, Zhang X, Zeng L, et al.
Leukemia
. 2012 Oct;
27(2):398-408.
PMID: 23103841
Internal tandem duplications (ITDs) in the fms-like tyrosine kinase receptor (FLT3-ITDs) confer a poor prognosis in acute myeloid leukemia (AML). We hypothesized that increased recruitment of the protein tyrosine phosphatase,...
6.
Derigs H, Morgan D, Hoffman R, Litz S, Srour E, Brandt J, et al.
Platelets
. 2010 Nov;
6(1):24-30.
PMID: 21043585
Terminal megakaryocytic development is characterized by nuclear poly ploidization, appearance of specific granules, and enhanced expression of membrane platelet glycoproteins. We utilized a human GM-CSF-dependent cell line, MB-02, which is...
7.
Cripe L, Gelfanov V, Smith E, Spigel D, Phillips C, Gabig T, et al.
Leukemia
. 2002 May;
16(5):799-812.
PMID: 11986940
A relationship was proved between constitutive activity of leukemic cell c-jun-N-terminal kinase (JNK) and treatment failure in AML. Specifically, early treatment failure was predicted by the presence of constitutive JNK...
8.
Gelfanov V, Burgess G, King A, Marshall M, Nakshatri H, Boswell H
Blood
. 2001 Oct;
98(8):2508-17.
PMID: 11588049
Tyrosine kinase oncogenes such as p210BCR-ABL activate multiple signal pathways. As a result, it is difficult to infer the functional relevance of a pathway acting alone or in cooperation with...
9.
Rizzo M, Regazzi E, Garau D, Akard L, Dugan M, Boswell H, et al.
Cancer Res
. 1999 Oct;
59(19):5047-53.
PMID: 10519422
The hallmark of chronic myeloid leukemia (CML) is the presence of the bcr-abl oncogene, which is associated with transforming ability and an intrinsic resistance to induction of apoptosis by genotoxic...
10.
Burgess G, Williamson E, Cripe L, Bhatt J, Stanley K, Stewart M, et al.
Blood
. 1998 Sep;
92(7):2450-60.
PMID: 9746785
Activity of the c-jun N-terminal kinase (JNK) has been shown in hematopoietic cells transformed by p210 BCR-ABL. However, analysis has not been reported for hematopoietic cells on the consequences of...